TipRanks
Icu Medical (CH:IC7)
:IC7
Switzerland Market
IC7
ICU Medical
RESEARCH TOOLSreports

ICU Medical (IC7) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

IC7 Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
ICU
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IC7 Stock 12 Month Forecast

Average Price Target

―
Based on 5 Wall Street analysts offering 12 month price targets for ICU Medical in the last 3 months. The average price target is CHF159.63 with a high forecast of CHF166.80 and a low forecast of CHF145.95. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF166.80Average Price TargetCHF159.63Lowest Price TargetCHF145.95
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on CH:IC7
Jason Bednar
Piper Sandler
Piper Sandler
CHF162.63
Buy
―
Reiterated
09/23/26
Analysts Offer Insights on NA Companies: Hexcel (NYSE: HXL), International Paper Co (NYSE: IP) and ICU Medical (NASDAQ: ICUI)
Raymond James Analyst forecast on CH:IC7
Jayson Bedford
Raymond James
Raymond James
CHF166.8
Buy
―
Reiterated
08/07/26
Raymond James Sticks to Their Buy Rating for ICU Medical (ICUI)
Needham Analyst forecast on CH:IC7
Michael Matson
Needham
Needham
CHF137.61→CHF155.96
Buy
―
Assigned
08/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG Analyst forecast on CH:IC7
Sam Eiber
BTIG
BTIG
CHF141.78→CHF166.8
Buy
―
Assigned
08/07/26
ICU Medical price target raised to $200 from $170 at BTIGICU Medical price target raised to $200 from $170 at BTIG
Jefferies Analyst forecast on CH:IC7
Michael Toomey
Jefferies
Jefferies
CHF145.95
Buy
―
Reiterated
07/16/26
Jefferies Reaffirms Their Buy Rating on ICU Medical (ICUI)
KeyBanc Analyst forecast on CH:IC7
Brett Fishbin
KeyBanc
KeyBanc
CHF136.78
Buy
―
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on CH:IC7
Jason Bednar
Piper Sandler
Piper Sandler
CHF162.63
Buy
―
Reiterated
09/23/26
Analysts Offer Insights on NA Companies: Hexcel (NYSE: HXL), International Paper Co (NYSE: IP) and ICU Medical (NASDAQ: ICUI)
Raymond James Analyst forecast on CH:IC7
Jayson Bedford
Raymond James
Raymond James
CHF166.8
Buy
―
Reiterated
08/07/26
Raymond James Sticks to Their Buy Rating for ICU Medical (ICUI)
Needham Analyst forecast on CH:IC7
Michael Matson
Needham
Needham
CHF137.61→CHF155.96
Buy
―
Assigned
08/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG Analyst forecast on CH:IC7
Sam Eiber
BTIG
BTIG
CHF141.78→CHF166.8
Buy
―
Assigned
08/07/26
ICU Medical price target raised to $200 from $170 at BTIGICU Medical price target raised to $200 from $170 at BTIG
Jefferies Analyst forecast on CH:IC7
Michael Toomey
Jefferies
Jefferies
CHF145.95
Buy
―
Reiterated
07/16/26
Jefferies Reaffirms Their Buy Rating on ICU Medical (ICUI)
KeyBanc Analyst forecast on CH:IC7
Brett Fishbin
KeyBanc
KeyBanc
CHF136.78
Buy
―
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ICU Medical

3 Months
Jason BednarPiper Sandler
Success Rate
8/10 ratings generated profit
80%
Average Return
+9.51%
Copying Jason Bednar's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.51% per trade.
1 Year
Jason BednarPiper Sandler
Success Rate
9/10 ratings generated profit
90%
Average Return
+19.04%
Copying Jason Bednar's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +19.04% per trade.
2 Years
Jason BednarPiper Sandler
Success Rate
9/10 ratings generated profit
90%
Average Return
+17.89%
Copying Jason Bednar's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +17.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IC7 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
8
7
7
7
6
Hold
2
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
8
7
7
6
In the current month, IC7 has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IC7 average Analyst price target in the past 3 months is 159.63.
Each month's total comprises the sum of three months' worth of ratings.

IC7 Financial Forecast

IC7 Earnings Forecast

Next quarter’s earnings estimate for IC7 is CHF1.73 with a range of CHF1.71 to CHF1.75. The previous quarter’s EPS was CHF1.92. IC7 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year IC7 has Performed in-line its overall industry.
Next quarter’s earnings estimate for IC7 is CHF1.73 with a range of CHF1.71 to CHF1.75. The previous quarter’s EPS was CHF1.92. IC7 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year IC7 has Performed in-line its overall industry.

IC7 Sales Forecast

Next quarter’s sales forecast for IC7 is CHF446.53M with a range of CHF444.81M to CHF451.93M. The previous quarter’s sales results were CHF446.58M. IC7 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year IC7 has Performed in-line its overall industry.
Next quarter’s sales forecast for IC7 is CHF446.53M with a range of CHF444.81M to CHF451.93M. The previous quarter’s sales results were CHF446.58M. IC7 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year IC7 has Performed in-line its overall industry.

IC7 Stock Forecast FAQ

What is CH:IC7’s average 12-month price target, according to analysts?
Based on analyst ratings, Icu Medical’s 12-month average price target is 159.63.
    What is CH:IC7’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:IC7, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Icu Medical a Buy, Sell or Hold?
        Icu Medical has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Icu Medical’s share price target?
          The average share price target for Icu Medical is 159.63. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF166.80 ,and the lowest forecast is CHF145.95. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Icu Medical?
            Icu Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of Icu Medical?
              To buy shares of CH:IC7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.